JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4976
Sprott Physical Gold and Silver Trust
CEF
$7.32B
| $149K | ﹤0.01% |
8,847
-527
| -6% | -$9.56K |
2018 Q1
17 quarters
|
|
4977
Cenntro
CENN
$9.75M
| $149K | ﹤0.01% |
164
-1,362
| -89% | -$1.44M |
2022 Q1
1 quarter
|
|
|
DBD
4978
DELISTED
Diebold Nixdorf Incorporated
DBD
| $149K | ﹤0.01% |
65,264
+2,330
| +4% | +$8.68K |
2013 Q2
36 quarters
|
|
|
KBAL
4979
DELISTED
Kimball International
KBAL
| $149K | ﹤0.01% |
19,408
+2,237
| +13% | +$18.3K |
2013 Q2
36 quarters
|
|
|
YELL
4980
DELISTED
Yellow Corporation Common Stock
YELL
| $149K | ﹤0.01% |
50,772
-98,504
| -66% | -$400K |
2021 Q1
5 quarters
|
|
|
FMTX
4981
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $148K | ﹤0.01% |
21,549
-114
| -0.5% | -$800 |
2020 Q3
7 quarters
|
|
4982
Kodak
KODK
$964M
| $147K | ﹤0.01% |
31,739
+9,587
| +43% | +$50K |
2017 Q4
18 quarters
|
|
|
STR
4983
DELISTED
Sitio Royalties
STR
| $147K | ﹤0.01% |
6,307
-129,309
| -95% | -$3.58M |
2019 Q1
13 quarters
|
|
4984
CALL
Truist Financial
TFC
$56.5B
| $147K | ﹤0.01% |
3,100
| – | – |
2021 Q3
3 quarters
|
|
|
VTYX
4985
DELISTED
Ventyx Biosciences
VTYX
| $147K | ﹤0.01% |
11,984
+4,391
| +58% | +$65.6K |
2021 Q4
2 quarters
|
|
|
APTX
4986
DELISTED
Aptinyx Inc. Common Stock
APTX
| $147K | ﹤0.01% |
263,954
| – | – |
2018 Q2
16 quarters
|
|
4987
Vita Coco
COCO
$3.3B
| $146K | ﹤0.01% |
14,907
+9,639
| +183% | +$102K |
2021 Q4
2 quarters
|
|
|
CPAC
4988
Cementos Pacasmayo
CPAC
$1.03B
| $146K | ﹤0.01% |
31,025
| – | – |
2018 Q3
15 quarters
|
|
4989
iShares MSCI Italy ETF
EWI
$1.07B
| $146K | ﹤0.01% |
6,048
-138,726
| -96% | -$3.8M |
2020 Q4
6 quarters
|
|
4990
Foghorn Therapeutics
FHTX
$173M
| $146K | ﹤0.01% |
10,744
+1,570
| +17% | +$20.3K |
2020 Q4
6 quarters
|
|
4991
SES AI
SES
$303M
| $146K | ﹤0.01% |
37,175
+20,630
| +125% | +$132K |
2022 Q1
1 quarter
|
|
4992
Fidelity MSCI Materials Index ETF
FMAT
$567M
| $145K | ﹤0.01% |
3,532
-332
| -9% | -$15.6K |
2022 Q1
1 quarter
|
|
4993
IES Holdings
IESC
$13.2B
| $145K | ﹤0.01% |
9,644
-3,564
| -27% | -$57.3K |
2017 Q4
18 quarters
|
|
|
DOMA
4994
DELISTED
Doma Holdings, Inc.
DOMA
| $144K | ﹤0.01% |
5,599
+1,837
| +49% | +$78.1K |
2021 Q1
5 quarters
|
|
|
OTLY
4995
Oatly Group
OTLY
$333M
| $143K | ﹤0.01% |
2,064
-3,636
| -64% | -$284K |
2021 Q2
4 quarters
|
|
4996
Aterian
ATER
$11M
| $142K | ﹤0.01% |
5,491
+4,476
| +441% | +$198K |
2020 Q3
7 quarters
|
|
4997
Vanguard Total World Bond ETF
BNDW
$1.85B
| $142K | ﹤0.01% |
+2,030
| New | +$144K |
2022 Q2
0 quarters
|
|
4998
Centrus Energy
LEU
$2.85B
| $142K | ﹤0.01% |
5,741
+1,143
| +25% | +$31.6K |
2021 Q2
4 quarters
|
|
4999
Lindblad Expeditions
LIND
$2.2B
| $142K | ﹤0.01% |
17,514
+2,858
| +20% | +$37.2K |
2017 Q4
18 quarters
|
|
5000
Offerpad Solutions Inc. Class A Common Stock
OPAD
$16M
| $142K | ﹤0.01% |
434
+431
| +14,367% | +$289K |
2021 Q3
3 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.